Y Klaver, M Rijnders, A Oostvogels, R Wijers, M Smid, D Grunhagen, C Verhoef, S Sleijfer, C Lamers, R Debets. Differential quantities of immune checkpoint-expressing CD8+ T cells in soft tissue sarcoma subtype. J Immunotherapy Cancer, under revision.

D Hammerl, J Martens, M Timmermans, M Smid, A Trapman-Jansen, R Foekens, O Isaeva, L Voorwerk, HE Balcioglu, R Wijers, I Nederlof, R Salgado, H Horlings, M Kok, R Debets. Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T-cell evasion in triple negative breast cancer. Can Disc, under review.

P Mutsaers, et al. V-domain Ig-containing suppressor of T-cell activation (VISTA) is an independent prognostic factor for survival in bone marrow derived myeloma plasma cells and co-localizes on tumor infiltrating CD11b+ myeloid derived suppressor cells. Manuscript in preparation.

C Phanthunane, et al. B-cell clusters at invasive margin provide prognostic value in early-stage oral-tongue cancer patients. Manuscript in preparation.

M Rijnders, et al. Response of metastatic urothelial cancer to anti-PD1 treatment is characterized by recruitment and activation of CD4 T cell subsets. Manuscript in preparation.

HE Balcioglu, et al. TME-Analyzer: A multi-dimensional visualization and analysis tool to capture immune contexture in tumor tissues. Manuscript in preparation.